Lieberman B A, Stirrat G M, Cohen S L, Beard R W, Pinker G D, Belsey E
Br J Obstet Gynaecol. 1978 Sep;85(9):678-83. doi: 10.1111/j.1471-0528.1978.tb14946.x.
A retrospective study is presented of the effect of propranolol on fetal outcome in pregnancies complicated by maternal hypertension. In nine pregnancies in which propranolol was given to markedly hypertensive women (diastolic blood pressure over 105 mm Hg) the fetal outcome was worse than in 15 patients using other hypotensive agents. The probability of fetal or neonatal death was related to the amount of proteinuria and the presence of parenchymal renal disease but was also significantly higher when the mother had been treated with propranolol. Experimental evidence suggests that beta-adrenergic blockade is harmful to the hypoxic fetus, for these reasons the use of propranolol in hypertensive pregnancies complicated by placental insufficiency may be contraindicated unless there is no satisfactory alternative.
本文呈现了一项关于普萘洛尔对妊娠合并母体高血压胎儿结局影响的回顾性研究。在9例给明显高血压妇女(舒张压超过105mmHg)使用普萘洛尔的妊娠中,胎儿结局比15例使用其他降压药的患者更差。胎儿或新生儿死亡的概率与蛋白尿的量和实质性肾病的存在有关,但当母亲接受普萘洛尔治疗时也显著更高。实验证据表明,β-肾上腺素能阻滞对缺氧胎儿有害,基于这些原因,除非没有令人满意的替代药物,否则在合并胎盘功能不全的高血压妊娠中使用普萘洛尔可能是禁忌的。